CDH1 promoter methylation was more prevalent in the Australian population compared to the South African population in the HCC tissues (30% in Australians and 13% in Africans) as well as in the ANT tissues (57% in Australians and 8% in Africans). The gene discussed is CDH1; the disease is hepatocellular carcinoma.